Overview
ISIN
IE00BJ7W3579SEDOL
BJ7W357Investment proposition
Share price and charges
Share class
B, Inc, GBPNAV per share
11.60% change
0.75%Ongoing charges*
0.89%Initial charge
0%Fund facts
Current number of holdings
64
Guideline number of holdings
50-75
Benchmark
MSCI ACWI Small Cap Index
Active share
99%**
Annual turnover
44%
Fund launch date
6 September 2017
Style
Global Smaller Companies
Fund Settlement Cycle
Trade date plus three business days (T+3)
Fund size calculated using base currency in US dollars and converted into listed currencies.
**Relative to MSCI All Country World Small Cap Index. Source: Baillie Gifford & Co, MSCI.
Meet the managers
Risks
General Investment Risk
Investment markets can go down as well as up and market conditions can change rapidly. The value of an investment in the Fund, and any income from it, can fall as well as rise and investors may not get back the amount invested. The specific risks associated with the Fund include:
Market Conditions
Any value assigned to illiquid securities which are difficult to trade, such as those in smaller, immature companies, may not accurately reflect the price the Fund might receive upon their sale.
Custody
Custody of assets involves a risk of loss if a custodian becomes insolvent or breaches duties of care.
Smaller, Immature Companies
Investment in smaller, immature companies is generally considered higher risk as the market for their shares may be less liquid and more difficult to trade than that for more established companies. As a result, share price fluctuations may be greater. In addition, smaller, immature companies may not do so well in periods of adverse economic conditions. Where such companies have business models and competitive positions which are less well established, this could result in an increased likelihood of loss for investors.
Concentration
The Fund's concentration in a particular geographical area or industry may result in large movements in the share price in the short term.
Foreign Currency
The Fund has exposure to foreign currencies and changes in the rates of exchange will cause the value of any investment, and income from it, to fall as well as rise and you may not get back the amount invested.
Environmental, Social and Governance
The Fund's approach to Environmental, Social and Governance (ESG) means it cannot invest in certain sectors and companies. The universe of available investments will be more limited than other funds that do not apply such criteria/ exclusions, therefore the Fund may have different returns than a fund which has no such restrictions. Data used to apply the criteria may be provided by third party sources and is based on backward-looking analysis and the subjective nature of non-financial criteria means a wide variety of outcomes are possible. There is a risk that data provided may not adequately address the underlying detail around material non-financial considerations. Please consider all of the characteristics and objectives of the fund as described in the Key Information Document (KID) and prospectus before making a decision to invest in the Fund. For more information on how sustainability issues, such as climate change are considered, see bailliegifford.com.
Volatility
The Fund's share price can be volatile due to movements in the prices of the underlying holdings and the basis on which the Fund is priced.
Further Details
Further details of the risks associated with investing in the Fund can be found in the Key Information Document (KID), or the Prospectus. Copies of both the KID and Prospectus are available at bailliegifford.com.
Definitions
Active Share - A measure of the Fund's overlap with the benchmark. An active share of 100 indicates no overlap with the benchmark and an active share of zero indicates a portfolio that tracks the benchmark.
Index disclaimer
Complaints
In the first instance, clients should contact their normal Client Contact with any concerns. Alternatively, or for those clients who do not have a direct client contact assigned, complaints can be emailed to Baillie Gifford’s Compliance Department at: InstitutionalComplaints@bailliegifford.com.
A summary document which contains details on Baillie Gifford’s complaints management policy is available upon request. All material complaints are recorded in an in-house incident management system and are escalated to, and dealt with by, members of staff of suitable seniority, independent of the area from which the matter arose.
Fund performance
Fund portfolio holdings
The list of top 10 holdings that this fund invests in.
As at: 30 April 2026
| # | Holding | % of total assets |
|---|---|---|
| 1 | Alnylam Pharmaceuticals | 5.3% |
| 2 | Twist Bioscience | 3.9% |
| 3 | Axon Enterprise | 3.7% |
| 4 | ASPEED Technology | 3.6% |
| 5 | American Superconductor Corp | 2.9% |
| 6 | Aehr Test Systems | 2.9% |
| 7 | Xometry, Inc. | 2.8% |
| 8 | MercadoLibre | 2.6% |
| 9 | Astera Labs | 2.6% |
| 10 | Oxford Nanopore Tech | 2.4% |
Sector
As at: 30 April 2026
# | Sector | Fund % | Index % * | Difference % |
|---|---|---|---|---|
| 1 | Information Technology | 32.8 | 14.3 | 18.5 |
| 2 | Health Care | 28.1 | 9.3 | 18.8 |
| 3 | Industrials | 23.9 | 20.5 | 3.4 |
| 4 | Consumer Discretionary | 4.6 | 10.4 | -5.8 |
| 5 | Financials | 4.5 | 13.8 | -9.3 |
| 6 | Real Estate | 2.4 | 7.5 | -5.1 |
| 7 | Materials | 1.5 | 9.1 | -7.6 |
| 8 | Consumer Staples | 1.1 | 4.2 | -3.1 |
| 9 | Cash | 1.1 | 0.0 | 1.1 |
Total | 100.0 | 89.1 |
Top 10 geographical locations
As at: 30 April 2026
# | Top 10 locations | Fund % | Index % * | Difference % |
|---|---|---|---|---|
| 1 | United States | 57.4 | 52.2 | 5.2 |
| 2 | UK | 7.3 | 3.6 | 3.7 |
| 3 | China | 6.0 | 1.5 | 4.5 |
| 4 | Japan | 5.4 | 10.8 | -5.4 |
| 5 | Brazil | 5.0 | 0.5 | 4.5 |
| 6 | Taiwan | 4.7 | 3.4 | 1.3 |
| 7 | Australia | 3.7 | 3.2 | 0.5 |
| 8 | Israel | 3.4 | 1.5 | 1.9 |
| 9 | France | 1.7 | 1.2 | 0.5 |
| 10 | Netherlands | 1.6 | 0.4 | 1.2 |
Total | 96.1 | 78.3 |
Region
As at: 30 April 2026
# | Region | Fund % | Index % * | Difference % |
|---|---|---|---|---|
| 1 | North America | 57.4 | 55.9 | 1.5 |
| 2 | Emerging Markets | 20.5 | 14.2 | 6.3 |
| 3 | Developed Asia Pacific | 9.1 | 15.2 | -6.2 |
| 4 | UK | 7.3 | 3.6 | 3.7 |
| 5 | Europe (ex UK) | 4.7 | 11.0 | -6.3 |
| 6 | Cash | 1.1 | 0.0 | 1.1 |
Total | 100.0 | 100.0 |
Quarterly transactions
Transactions for the three-month period ending 31 March 2026
New purchases
- Circle Internet Group
- Rubrik
- Stoke Therapeutics, Inc. Com
Complete sales
- SkyWater Technology
- Upwork Inc
Insights
Key articles, videos and podcasts relating to the fund:
Filters
Insights

Discovery Q1 update
Investment specialist Bill Chater reflects on recent performance, portfolio changes and market developments.
Discovery Q4 update
Investment specialist Bill Chater reflects on recent performance, portfolio changes and market developments.
Discovery Q3 update
Investment specialist Bill Chater reflects on recent performance, portfolio changes and market developments.
Discovery Q2 update
Investment manager Douglas Brodie reflects on recent performance, portfolio changes and market developments.
Alnylam: Stock Story
Richie Vernon explores the revolutionary drugs transforming patient lives.
Discovery Q1 update
The Discovery Team reflects on recent performance, portfolio changes and market developments.
Discovery: our philosophy
Investment manager, Douglas Brodie, discusses the Baillie Gifford Discovery Strategies.
Our best disruptive ideas
Bill Chater spotlights three companies making world-changing breakthroughs: Alnylam, Axon and SpaceX.
Global Discovery manager update
Hear why investors’ confidence in the Strategy remains steadfast despite challenging times.
Small caps: Beyond the myths
Opportunities remain in small-cap investing, regardless of interest rates or market volatility.
Global Discovery manager update
Investors discuss recent performance, holdings, and portfolio positioning for the Global Discovery Strategy.

Discovery Q1 update
Investment specialist Bill Chater reflects on recent performance, portfolio changes and market developments.
Discovery Q4 update
Investment specialist Bill Chater reflects on recent performance, portfolio changes and market developments.
Discovery Q3 update
Investment specialist Bill Chater reflects on recent performance, portfolio changes and market developments.
Discovery Q2 update
Investment manager Douglas Brodie reflects on recent performance, portfolio changes and market developments.
Alnylam: Stock Story
Richie Vernon explores the revolutionary drugs transforming patient lives.
Discovery Q1 update
The Discovery Team reflects on recent performance, portfolio changes and market developments.
Discovery: our philosophy
Investment manager, Douglas Brodie, discusses the Baillie Gifford Discovery Strategies.
Our best disruptive ideas
Bill Chater spotlights three companies making world-changing breakthroughs: Alnylam, Axon and SpaceX.
Global Discovery manager update
Hear why investors’ confidence in the Strategy remains steadfast despite challenging times.
Small caps: Beyond the myths
Opportunities remain in small-cap investing, regardless of interest rates or market volatility.
Global Discovery manager update
Investors discuss recent performance, holdings, and portfolio positioning for the Global Discovery Strategy.
How to invest
You can invest in our funds through a wide range of investment platforms. If your preferred platform does not currently offer our funds, they may be made available upon request by contacting the platform directly.
Baillie Gifford does not sponsor, maintain, or have any control over the content of any other websites. Therefore, we are not responsible for the adequacy or accuracy of any of the information you may view, nor do we undertake to ensure successful transmission to any linked website.
Documents
Documents
You can access any literature about the Fund here.
To download any document you will need Adobe Reader. Please note that we can now provide you with Braille and audio transcriptions of our literature on request. It may take up to 10 days for the transcription to be completed dependent on the size of the document.



